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ABSTRACT Cellular spheroids serving as three-dimensional 
(3D) in vitro tissue models have attracted increasing interest 
for pathological study and drug-screening applications. 
Various methods, including microwells in particular, have 
been developed for engineering cellular spheroids. However, 
these methods usually suffer from either destructive molding 
operations or cell loss and non-uniform cell distribution 
among the wells due to two-step molding and cell seeding. 
We have developed a facile method that utilizes cell-
embedded hydrogel arrays as templates for concave well 
fabrication and in situ MCF-7 cellular spheroid formation on 
a chip. A custom-built bioprinting system was applied for 
the fabrication of sacrificial gelatin arrays and sequentially 
concave wells in a high-throughput, flexible, and controlled 
manner. The ability to achieve in situ cell seeding for cellular 
spheroid construction was demonstrated with the advantage 
of uniform cell seeding and the potential for programmed 
fabrication of tissue models on chips. The developed method 
holds great potential for applications in tissue engineering, 
regenerative medicine, and drug screening.
KEYWORDS MCF-7 cellular spheroids, bioprinting, hydrogels, 
concave wells, tissue on a chip
1 Introduction
In vitro tissue models such as those based on cellular sphe­
roids have attracted increasing interest in cellular biology, tis­
sue engineering, regenerative medicine, and drug­screening 
applications [1–4]. Cellular spheroids are three­dimensional 
(3D) aggregates of multi­cells, which usually scale from tens 
to hundreds of micrometers. It is widely accepted that cells 
in cellular spheroids behave and respond to changes in mi­
croenvironment cues in a much more natural manner than 
those on traditional two­dimensional (2D) culture plates [5, 
6]. In addition, cellular spheroids are inherently scaffold free 
as compared to scaffold­based 3D models; this property may 
help cellular spheroids to avoid biocompatibility issues [7]. 
Different types of cells have been engineered into cellular 
spheroids, including normal [8, 9], cancerous [10, 11], and 
stem cells [12, 13], as well as a mixture of cell types [14, 15]. In 
particular, the introduction of chip technologies has recently 
inspired the emergence and prominent development of tis­
sue/organ­on­a­chip technology, which is believed to hold 
great promise in biomedical fields [16–18].
Various methods have been developed for generating cel­
lular spheroids by exploring the fluidic and self­assembly 
abilities of cells [19]. A facile method is to culture cells on 
non­adherent substrates [20], where the cell­cell interaction is 
stronger than that of cell­substrate, resulting in the aggrega­
tion of cells. To promote the assembly of cells, gravitational 
and magnetic forces have been explored, leading to the de­
velopment of the hanging­drop [21] and magnetic­levitation 
methods [22], respectively. Microwells have also been widely 
used to confine the growth space of cells with the benefit of 
forming cellular spheroids with controlled and uniform size 
[11]. Among these methods, microwells have attracted in­
creasing attention; especially those with concave structures, 
due to advantages such as easy operation, good controllabili­
ty, and high­throughput capacity [23, 24]. However, almost all 
of the current microwell methods require the manual seed­
ing of cells after the preparation of a microwell plate, which 
may be cumbersome and can cause cell loss and non­uniform 
cell seeding [25]. In addition, special templates and a careful 
molding process are required to obtain well-defined concave 
microwells, which limits their accessibility. Therefore, there 
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is still an urgent need for a flexible manufacturing method for fabricating cellular 
spheroids, particularly those with the potential for engineering tissues on chips.
In this study, we developed a bioprinting­based method for fabricating concave 
wells and generating cellular spheroids in situ on a chip. A custom­built bioprinting 
system was first constructed and applied in order to generate cell-laden sacrificial 
gelatin arrays. These cell­laden gelatin arrays were subsequently used as templates 
for fabricating concave wells and forming cellular spheroids on a non­adhesive hy­
drogel substrate. The method is facile and, to the best of our knowledge, represents 
the first use of biocompatible hydrogels as templates for fabricating concave wells 
with in situ cell­seeding ability for cellular spheroid formation.
2 Materials and methods
2.1 Set-up and improvement of the bioprinting system
To get high controllability for the droplet generation of gelatin sol, a pressure­
assisted value­based bioprinting system was applied. This system was custom built, 
and is shown in Figure 1(a). The system was set up in a vertical laminar-flow clean 
workbench, with the main components being a three­axis motion stage (KDT180­
100­LM (XY) and MT105­50­LM (Z), Feinmess Dresden GmbH, Dresden, Germany), 
a solenoid valve ejector (Model G100­150300, TechElan, Mountainside, NJ, USA), and 
a digital signal generator (Agilent 81101A, Test Equipment Connection, Lake Mary, 
FL, USA). All of these components were controlled using a computer.
line (PBS) solution at a concentration of 
3% (w/v) and gently stirred at 50 °C un­
til fully dissolved. The sol solution was 
then water­bathed to 37 °C, transferred 
to the sample­holding syringe, and 
printed onto a culture petri dish coated 
with a polytetrafluoroethene (PTFE) 
membrane. The PTFE membrane was 
used because it is physically hydropho­
bic and chemically inert, as well as easy 
to use. The temperature of the gelatin 
solution in the syringe was kept at 37 °C 
during printing. The assisted printing 
pressure and pulse width of the signal 
were adjusted to control the printed 
volume of the gelatin droplet and thus 
the size and shape of the gelatin arrays. 
The petri dish with the printed gelatin 
arrays was immediately transferred to 
a refrigerator and cooled at 4 °C for 5 
min in order to gel the gelatin precusor.
2.3 Gelatin-array templated fabrication of 
concave wells
Polyethylene glycol (PEG)­based hy­
drogels were used to mold concave 
wells from gelatin arrays due to their 
biocompatibility, photocrosslinkability, 
and cell­nonadhesive properties. These 
hydrogels have also been used by oth­
ers to fabricate wells for the formation 
of cellular spheroids [26–28]. In our 
experiment, PEG­dimethacrylate (PEG­
DMA, MW 1000, Polysciences, Inc., 
Warrington, PA, USA) was dissolved in 
a PBS solution at a concentration of 20% 
(w/v) and then cooled to 4 °C. After be­
ing poured onto the petri dish with the 
gelatin arrays, the PEG­DMA solution 
was exposed to 365 nm ultraviolet (UV) 
light with a power of 2.9 mW.cm–2 (Mod­
el XLE­1000 A/F, Spectroline, Westbury, 
NY, USA) for 20 s for gelling. During 
the photocrosslinking, 2­hydroxy­
2­methylpropiophenone (TCI Shang­
hai Development Co., Ltd., Shanghai, 
China) was used as the photoinitia­
tor at a concentration of 0.1% (w/v). 
After incubation at 37 °C for 24 h, the 
gelatin arrays redissolved into a sol 
phase and concave wells formed on the 
PEG­DMA substrate.
2.4 Characterization of gelatin arrays and 
concave wells
The gelatin arrays were imaged with 
an inverted fluorescence microscope 
(Olympus IX 81, Olympus, Irvine, CA, 
USA) before molding with PEG­DMA. 
Figure 1. Bioprinting platform. (a) Image of the bioprinting platform; (b) mean droplet volume as a function 
of pneumatic pressure, and the valve-opening duration is 5 ms; (c) mean droplet volume as a function of 
valve-opening duration, and the pneumatic pressure is 0.05 MPa. Error bars represent standard error (n = 5).
2.2  Bioprinting-based fabrication of sacrificial gelatin arrays
Gelatin was chosen for the sacrificial hydrogel arrays due to its biocompatibility 
and its injectable and reversible gelling abilities under mild temperature condi­
tions. To fabricate the gelatin arrays, porcine­skin gelatin powder (gel strength 300, 
Type A, Sigma­Aldrich, St. Louis, MO, USA) was added to a phosphate­buffered sa­
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To image the wells, the PEG­DMA substrate was gently de­
tached from the PTFE­covered petri dish, and swelled to 
equilibrium in a PBS solution. After being taken out of the 
PBS solution, the excess PBS solution on the PEG­DMA sub­
strate surface and in the wells was gently removed with blot­
ting paper. To capture a cross­section of the wells, the PEG­
DMA substrate was carefully cut through the wells with a 
razor blade and images were immediately taken with an IX 
81 microscope. The images were analyzed with Image­Pro 
Plus (IPP, version 6.0, Media Cybernetics, Silver Spring, Rock­
ville, MD, USA) to quantify the sizes of the gelatin arrays and 
wells on the PEG­DMA substrate.
2.5 In situ cell seeding and cellular spheroid formation
We used MCF­7 human breast cancer cells to verify the in 
situ cell­seeding ability of our method for the high­through­
put fabrication of cellular spheroids on a chip. Cells were 
cultured in RPMI 1640 medium (HyClone, South Logan, UT, 
USA) and supplemented with 10% fetal bovine serum (Gibco 
Industries, Inc., Big Cabin, OK, USA) in a humidified 5% 
CO2 incubator at 37 °C. Before the experiment, the cells were 
digested with trypsin (EDTA 1×, Mediatech, Inc., Manassas, 
VA, USA) and centrifuged, and the liquid supernatant was re­
moved. The cells were then resuspended in the culture medi­
um. The prepared cellular suspension was then gently mixed 
with a pre­filtered gelatin solution at a final cell density of 
5 × 105 cells.mL–1 to 1 × 106 cells.mL–1 and a gelatin concentra­
tion of 3% (w/v) at 37 °C. The cell­gelatin mixture was then 
loaded into the syringe for the fabrication of the gelatin ar­
rays and wells as described in Sections 2.2 and 2.3. The petri 
dish cover was removed after incubation for 1 h and the cell 
culture medium was changed daily. Phase­contrast images 
of the cellular spheroids were observed with an Olympus IX 
81. Confocal fluorescence images (LSM700, ZEISS, New York, 
NY, USA) were observed after the spheroids or aggregates 
were stained using a live/dead viability/cytotoxicity kit (In­
vitrogen, Washington, DC, USA). The kit stained live cells 
green with calcein AM and dead cells red with ethidium ho­
modimer-1. Cell viability was quantified from confocal slices 
using IPP.
3 Results and discussion
The bioprinting system we constructed is shown in Figure 
1(a). High controllability of the bioprinting system for pro­
ducing droplets of nL volume was demonstrated; this control­
lability can be achieved by changing the pneumatic pressure 
or the valve­opening duration, as shown in Figure 1(b) and 
Figure 1(c), respectively. The optimized concentration of the 
gelatin sol solution was found to be ~3% (w/v), below which 
the gelatin arrays were too soft to be used as templates and 
above which valve blocking and solution ponding occurred.
The bioprinting system was then applied to produce con­
trolled gelatin arrays for fabricating concave wells and in 
situ cellular spheroid formation, as illustrated in Figure 2. 
First, gelatin arrays of different sizes were created on a hy­
drophobic PTFE­covered petri dish, as shown in Figure 3(a–
c). After molding, concave wells were formed on the PEG­
DMA substrate with almost the same size as the gelatin­array 
templates, as shown in Figure 3(d–f), demonstrating the high 
molding fidelity and thus the feasibility of using gelatin ar­
rays as templates. By tuning the volume of the printed gelatin 
droplets from 0.1 mL to 0.48 mL, gelatin arrays with a radius 
ranging from 420 mm to 530 mm and a depth ranging from 
230 mm to 550 mm can be easily obtained, as shown in Figure 
3(g). This method led to the formation of concave wells with 
a radius ranging from 480 mm to 530 mm and a depth ranging 
from 250 mm to 550 mm, as shown in Figure 3(h). The droplet 
volume can be easily tuned by adjusting either the printing 
pressure or the pulse width of the digital signal. Since high 
pressure may lead to cell damage and an unwantedly force­
ful impact between the gelatin droplet and the substrate, 
we only tuned the pulse signal width to control the gelatin 
droplet volume. Wells with a high depth may have the ad­
vantage of avoiding cell loss during the medium exchange. 
We expect that wells with a much more controlled size and a 
higher molding fidelity could be fabricated by optimizing the 
production of the gelatin arrays, which may be achieved by 
improving the gelatin droplet hydrophobic angle by use of 
more hydrophobic substrates.
To prove the in situ cell­seeding ability of our method for 
cellular spheroid formation on a chip, we first mixed MCF-7 
cells with a gelatin precursor at a density of 1 × 106 cells.mL–1 
and printed the mixture at a volume of 0.48 mL per droplet. 
After molding and incubation at 37 °C for 1 h, the gelatin 
arrays reversed to the sol phase and the cells, encapsulated 
in gelatin, were released and deposited onto the bottom of 
Figure 2. Schematics of concave-well fabrication and in situ cell seeding 
for cellular spheroid formation. (a) Cover the petri dish with a film layer of 
hydrophobic PTFE; (b) print gelatin and cell solution onto PTFE-covered petri 
dish; (c) cell-encapsulated hydrogel array forms when cooled at 4 °C; (d) pour 
the cold PEG-DMA solution onto the cell-encapsulated gelatin array and (e) 
expose it to UV light for crosslinking; (f) turn it over and incubate at 37 °C to 
liquefy the gelatin and release cells onto the well bottom; (g) cellular spheroids 
form during further culture.
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spheroids on the 7th day, as shown 
in Figure 4(a). We observed very few 
dead cells throughout the process, as 
shown in Figure 4(b). Cellular spher­
oid formation with a printed volume 
of 0.23 mL and the same cell­seeding 
density (i.e., 1 × 106 cells.mL–1) was also 
studied. Although cellular aggregates 
were observed after 7 days of culture, 
these were not as compacted as those in 
the 0.48 mL group, as shown in Figure 
4(c). The observed cellular aggregates 
did not change notably even after 14 
days of culture (results not shown 
here). The horizontal cross­sectional 
confocal fluorescence image in Figure 
4(b) shows that there is a black central 
domain without stained cells, which 
may be induced by diffusion limitation 
of the live/dead solution in compacted 
cellular spheroids. This central domain 
is not observed in Figure 4(d), indicat­
ing that the formed cellular aggregates 
with a printed gelatin volume of 0.23 
mL may be in a disk shape. From Figure 
3(f) and Figure 3(h), we know that the 
fabricated wells with printed gelatin 
volumes of 0.23 mL and 0.48 mL per 
droplet have radiuses of 480 mm and 
530 mm, and depths of 390 mm and 550 
mm, respectively. Thus, it seems to us 
that well depth may play an important 
role in the formation of compacted cel­
lular spheroids.
We further investigated the influence 
of initial in situ cell­seeding density 
Figure 3. Controlled fabrication of hydrogel concave wells. (a) Overall view of printed gelatin arrays 
of different sizes on a PTFE-covered petri dish; (b) top-view microscope image of the gelatin arrays; 
(c) side view of two typical gelled gelatin droplets; (d) overall view of concave wells formed on PEG-DMA; 
(e) top-view microscope image of PEG-DMA wells; (f) side view of the cross-section of the concave wells; 
(g) controllability of the sizes of gelatin arrays; (h) controllability of the sizes of concave wells. Scale bars in (b), 
(c), (e), and (f) are 0.5 mm. Error bars in (g) and (h) represent standard deviation (n = 5).
Figure 4. Cellular spheroid formation in hydrogel 
concave wells. (a) Phase-contrast images of cellular 
spheroid development and (b) calcein and ethidium 
bromide staining of cells after 7 days of culture in wells 
made of 0.48 μL gelatin droplets and with a cell-seeding 
density of 1 × 106 cells·mL–1; (c) phase-contrast images 
of cellular spheroid development and (d) calcein and 
ethidium bromide staining of cells after 7 days of culture 
in wells made of 0.23 μL gelatin droplets and with a 
cell-seeding density of 1 × 106 cells·mL–1; (e, f) phase-
contrast images of cellular spheroid formation after 7 
days of culture in wells made of (e) 0.48 μL and (f) 0.23 
μL gelatin droplets, with a cell-seeding density of 5 × 
105 cells·mL–1; (g, h) live/dead fluorescence images 
corresponding to (e) and (f), respectively; (i) cell viability 
during cellular spheroid formation. Scale bars in (a)–(h) 
are 200 μm.
wells formed on the PEG­DMA substrate. During the subsequent culture, the cells 
proliferated, huddled together, and finally self-assembled into compacted cellular 
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on the formation of cellular spheroids. The results clearly 
showed that much smaller cellular spheroids were formed at 
a cell­seeding density of 5 × 105 cells.mL–1, as shown in Figure 
4(e)–(h), compared to a density of 1 × 106 cells.mL–1, as shown 
in Figure 4(a)–(d). Therefore, it is possible to control the size 
of cellular spheroids by adjusting the in situ cell­seeding den­
sity. Figure 4(i) shows that high cell viability was maintained 
during cellular spheroid formation. In addition, cell loss was 
effectively avoided with the in situ cell­seeding ability. More­
over, uniform distribution of seeded cells between wells was 
achieved due to the controllability of the bioprinting system. 
Morphologically speaking, cellular spheroids can better 
mimic the structure of organoids and thus the microenviron­
ment of cancer cells in vivo than can traditional 2D culture 
plates. It is therefore expected that MCF­7 may behave simi­
larly in cellular spheroids and in vivo. To demonstrate this, 
further studies including a drug test are needed; these will 
be our next work. Although we only tested MCF­7 cells here, 
we believe that other cell types can be used, since gelatin 
has been widely applied for cell encapsulation and since a 
polyethylene glycol (PEG) hydrogel­based well plate has been 
successfully used for producing cellular spheroids of various 
cell types, including embryonic stem cells [29, 30].
Several researchers have demonstrated the use of molded 
or printed gelatin sacrificial elements for fabricating micro­
fluidic hydrogels. In this work, we employed gelatin arrays 
as templates for the first time to generate concave wells for 
cellular spheroid formation. Although other templates, in­
cluding solid resin mold, SU­8, polydimethylsiloxane (PDMS), 
and ice array, have been developed for fabricating concave 
wells, these methods suffer from either cumbersome mold 
preparation or destructive demolding operations [23, 31–33]. 
In addition, the post manual cell­seeding step may cause 
cell loss and non­uniform cell distribution. Here, by using a 
biocompatible and temperature­reversible cell­laden gelatin­
array template, we provide a possible solution to overcome 
the above limitations. Moreover, the use of a custom­built 
bioprinting system may enable us to fabricate cellular spher­
oids in situ on a chip in a controlled and high­throughput 
manner, which will be of great help in engineering tissues on 
chips.
4 Conclusions
This work demonstrated the fabrication of concave wells 
molded from a hydrogel array with in situ seeding of cells for 
cellular spheroid formation on a chip. The use of a custom­
built bioprinting approach endows the method with high 
controllability and a high­throughput capacity. The integra­
tion of bioprinting and in situ cell seeding with gelatin may 
enable highly programmed fabrication of cells/tissues on 
chips, and thus holds great promise for tissue engineering, 
regenerative medicine, and drug­screening applications.
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